Dynamic cardiomyoplasty as a therapeutic alternative: current status

Area of Science:

• Cardiovascular Surgery
• Regenerative Medicine
• Biomedical Engineering

Background:

• Dynamic cardiomyoplasty (DCM) is a surgical option for severe cardiomyopathies.
• Over 1,000 patients worldwide have undergone DCM for dilated or ischemic cardiomyopathies.
• DCM aims to improve ventricular function and reverse adverse cardiac remodeling.

Purpose of the Study:

• To evaluate the efficacy and outcomes of dynamic cardiomyoplasty.
• To assess the impact of DCM on ventricular function, remodeling, and patient survival.
• To determine optimal patient selection and timing for dynamic cardiomyoplasty.

Main Methods:

• Surgical implantation of a synchronized skeletal muscle flap around the ventricle.
• Use of myostimulators to enhance skeletal muscle flap function.
• Clinical follow-up assessing ventricular function, chamber remodeling, and New York Heart Association (NYHA) functional class.

Main Results:

• Observed improvement in ventricular function due to synchronized muscle contraction and a girdling effect.
• Reduced ventricular wall stress and reversal of chamber remodeling.
• Reported 5-year survival rates between 39% and 54%, with higher mortality in NYHA class IV patients.
• Clinical improvement noted consistently, with potential for enhanced quality of life in NYHA class III patients.

Conclusions:

• Dynamic cardiomyoplasty can improve cardiac function and reverse remodeling in severe cardiomyopathies.
• Early intervention, particularly in NYHA functional class III patients, is crucial for better outcomes.
• Technological advancements may mitigate risks like skeletal muscle ischemia, improving long-term benefits.